The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global oxygenators market size reached US$ 228.46 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 329.81 Million by 2027, exhibiting a growth rate (CAGR) of 6.10% during 2022-2027.
An oxygenator refers to a medical device that is routinely used in medical settings to help exchange oxygen and carbon dioxide from the patient’s blood during surgical procedures. The device is used in conjunction with a heart-lung machine to facilitate gas exchange during procedures in which the blood flow is interrupted or stopped. These devices are widely used to manage heart-related disorders, such as cardiopulmonary, respiratory, and pulmonary disorders. As a result, these devices are commonly used in numerous critical surgical procedures, including cardiopulmonary bypass grafts (CABG) and coronary artery bypass grafts (CABG).
The global market is primarily driven by the growing number of hospital admissions due to the rising prevalence of numerous coronary, orthopedic and cardiovascular diseases among the masses. This can be attributed to the sedentary lifestyles led by individuals, resulting in various lifestyle-related ailments and a considerable rise in the requirement for surgical interventions. Additionally, the growing geriatric population that is susceptible to developing these diseases is also acting as a significant growth factor in the market. Additionally, the rising government investments in healthcare digitization, advanced infrastructure setup, and continual product innovations are fueling the market. As a result of improved healthcare settings, there has been a significant increase in the demand and sales for oxygenator devices across healthcare facilities on the global level. Some of the other factors contributing to the market include the increasing mergers and acquisitions (M&As) between key players, the augmenting cases of severe COVID-19 across the globe, various favorable healthcare reimbursement initiatives, and extensive research and development (R&D) activities conducted by multiple major players to introduce advanced medical devices in the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global oxygenators market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, age group and application.
Breakup by Type:
Breakup by Age Group:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Braile Biomédica, Chalice Medical Ltd, Eurosets S.r.l., Getinge AB, Livanova Plc, Medtronic plc, MicroPort, Nipro Corporation, Senko Medical Instrument Mfg. Co. Ltd., Terumo Medical Corporation (Terumo Corporation) and Xenios AG (Fresenius Medical Care AG & Co. KGaA).
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Age Group, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Braile Biomédica, Chalice Medical Ltd, Eurosets S.r.l., Getinge AB, Livanova Plc, Medtronic plc, MicroPort, Nipro Corporation, Senko Medical Instrument Mfg. Co. Ltd., Terumo Medical Corporation (Terumo Corporation) and Xenios AG (Fresenius Medical Care AG & Co. KGaA).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at